VERITY Wealth Advisors lowered its stake in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 10.7% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 12,404 shares of the financial services provider’s stock after selling 1,481 shares during the quarter. iShares Nasdaq Biotechnology ETF comprises 1.3% of VERITY Wealth Advisors’ portfolio, making the stock its 19th largest position. VERITY Wealth Advisors’ holdings in iShares Nasdaq Biotechnology ETF were worth $1,353,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently made changes to their positions in IBB. Mercer Global Advisors Inc. ADV bought a new stake in shares of iShares Nasdaq Biotechnology ETF in the first quarter valued at about $289,000. Leavell Investment Management Inc. acquired a new stake in shares of iShares Nasdaq Biotechnology ETF in the first quarter valued at about $215,000. Nwam LLC increased its position in shares of iShares Nasdaq Biotechnology ETF by 1.9% in the first quarter. Nwam LLC now owns 8,327 shares of the financial services provider’s stock valued at $931,000 after acquiring an additional 153 shares during the last quarter. Appleton Partners Inc. MA increased its position in shares of iShares Nasdaq Biotechnology ETF by 0.7% in the first quarter. Appleton Partners Inc. MA now owns 54,094 shares of the financial services provider’s stock valued at $6,048,000 after acquiring an additional 365 shares during the last quarter. Finally, Carroll Financial Associates Inc. increased its position in shares of iShares Nasdaq Biotechnology ETF by 45.7% in the first quarter. Carroll Financial Associates Inc. now owns 6,676 shares of the financial services provider’s stock valued at $746,000 after acquiring an additional 2,093 shares during the last quarter. Institutional investors own 74.63% of the company’s stock.

Shares of NASDAQ:IBB traded down $0.15 during midday trading on Thursday, reaching $102.88. The company had a trading volume of 160,939 shares, compared to its average volume of 2,203,167. The company’s 50 day moving average is $106.29. iShares Nasdaq Biotechnology ETF has a 1-year low of $89.01 and a 1-year high of $122.97.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Further Reading: Golden Cross

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.